# Development of a screening questionnaire for cognitive decline in patients with schizophrenia: diagnostic performance and clinical utility - URL: https://alisanburak.com/en/wcp-2026-posterler/ev1249 - Language: en - Last updated: not specified - Page title: Development of a screening questionnaire for cognitive decline in patients with schizophrenia: diagnostic performance and clinical utility | WCP 2026 Summary > Preliminary analyses identified learning and processing speed as the optimal combination for an ultra-brief, two-item screening questionnaire. This page was translated automatically from Turkish. [Read the original](https://alisanburak.com/wcp-2026-posterler/ev1249) This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it. EV1249 E-PosterPsychosis and SchizophreniaScale development and diagnostic accuracy study (preliminary findings) # Development of a screening questionnaire for cognitive decline in patients with schizophrenia: diagnostic performance and clinical utility DEVELOPMENT OF THE SCREENING QUESTIONNAIRE OF COGNITIVE DECLINE IN PATIENTS WITH SCHIZOPHRENIA: DIAGNOSTIC PERFORMANCE AND CLINICAL UTILITY Presenter: Chika Sumiyoshi Country: Japan Institution: Fukushima University, Faculty of Human Development and Culture Preliminary analyses identified learning and processing speed as the optimal combination for an ultra-brief, two-item screening questionnaire. The aim is to report the development of an ultra-brief, two-item screening questionnaire to address the need for an easy-to-administer, reliable screening tool for cognitive decline, which affects most patients with schizophrenia and determines occupational outcomes. More than 500 patients with schizophrenia were to be recruited from centers affiliated with the COCORO (Cognitive Genetics Collaborative Research Organization) network in Japan. One potential domain was identified from eight candidate cognitive domains based on its ability to discriminate cognitive decline, and candidate item pairs (dyads) were formed by pairing one question from this domain with one question from each of the other domains. Cognitive decline was defined as the difference between current estimated intelligence quotient (estimated IQ, EIQ; WAIS-III Symbol Search and Similarities subtests) and premorbid intelligence quotient (Japanese Adult Reading Test, JART). The outcome variable was dichotomized into declined (EIQ–JART of -15 or below) and mildly declined/preserved (above -15). Current cognitive functioning was measured using the Brief Assessment of Cognition in Schizophrenia (BACS). The screening performance of the candidate dyads was evaluated using receiver operating characteristic (ROC) curve analyses, and clinical utility was assessed using positive and negative predictive values (PPV/NPV). Only preliminary findings were presented because the study had not yet been completed. Among the potential domains, learning yielded the highest area under the curve (AUC), with relatively high AUC values also found for comprehension, problem-solving, planning, and processing speed. Learning and processing speed were identified as the optimal dyad, with adequate screening performance (sensitivity above 0.7 and PPV above 0.6). Its validity was supported by a stronger correlation with actual cognitive decline (EIQ–JART) than that of the other candidate dyads. Once finalized, this ultra-brief form, which can be administered in under 1–2 minutes and requires no training or preparation, may enable time- and resource-efficient screening for cognitive impairment in general clinical settings. [View the original poster](https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/858) How to cite this study APA 7: Sumiyoshi, C., et al. (2026, September 23-26). Development of the screening questionnaire of cognitive decline in patients with schizophrenia: diagnostic performance and clinical utility [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/858 Vancouver: Sumiyoshi C, et al. Development of the screening questionnaire of cognitive decline in patients with schizophrenia: diagnostic performance and clinical utility [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/858 Author names and title formatting were generated automatically from the congress system; please check them against the original poster before use. ## On the same topic - [İlk atak psikoz ve esrar kullanım bozukluğu olan gençlerde yardım arama: Back to Reality video oyun serisinden çıkarımlar](https://alisanburak.com/en/wcp-2026-posterler/ev0002) - [Kimyasal bağımlılığın eşlik ettiği tedaviye dirençli şizofreni hastalarında modern antipsikotiklerin kombine kullanımının klinik sonuçları](https://alisanburak.com/en/wcp-2026-posterler/ev0014) - [Şizofrenide bilişsel gerileme: Sosyal işlevsellik üzerindeki etkisi ve bilişsel iyileştirme olanakları](https://alisanburak.com/en/wcp-2026-posterler/ev0018) - [Ağır kişilerarası şiddet öyküsü olan, şizofrenisi olan ve olmayan bireylerde temel benlik bozukluklarının karşılaştırılması](https://alisanburak.com/en/wcp-2026-posterler/ev0103) - [Yoğun çakra odaklı meditasyonla ilişkili bir ergende akut ve geçici psikotik bozukluk: olgu sunumu](https://alisanburak.com/en/wcp-2026-posterler/ev0231) [All WCP 2026 summaries](https://alisanburak.com/en/wcp-2026-posterler) --- Kaynak / Source: https://alisanburak.com/en/wcp-2026-posterler/ev1249 İletişim / Contact: Bağdat Caddesi, Veli Güneysu Apt. No:453 K:4 D:9, Suadiye / Kadıköy, İstanbul · +90 532 642 95 25 · info@alisanburak.com · https://alisanburak.com/bagdat-caddesi-psikoterapi-iletisim